New human data hints at psychedelics' potential to combat inflammation
Global - North America
Archived
•
October 21, 2026
•
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
Source: NPR News | https://feeds.npr.org/1001/rss.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



